| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,038 |
9,168 |
$449K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
552 |
478 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
265 |
123 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
27 |
25 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
79 |
66 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,462 |
1,039 |
$998.37 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
509 |
397 |
$889.44 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
124 |
100 |
$371.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
237 |
208 |
$87.05 |
| 3074F |
|
301 |
263 |
$29.00 |
| 3078F |
|
220 |
195 |
$23.00 |
| 3079F |
|
95 |
89 |
$9.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
15 |
12 |
$0.14 |
| 99406 |
|
45 |
30 |
$0.00 |